| Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| Use of compound active on the sigma receptor for the treatment of mechanical allodynia |
| Use of compounds active on sigma receptors for the treatment of mechanical allodynia |
| Use of compounds active on the sigma receptor for the treatment of allodynia |
| Use of compounds active on the sigma receptor for the treatment of mecanical allodynia |
| Use of compounds active on the sigma receptor for the treatment of neuropathic pain |
| Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| Use of maslinic acid for treating nociceptive, inflammatory and neurogenic pain |
| Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy |